Ophthalmic inflammation and allergic eye disease
Research activity includes vernal keratoconjunctivitis, with interest in controlling keratitis, ocular surface inflammation, and symptoms affecting the cornea and surrounding tissues.
- Vernal keratoconjunctivitis
- Corneal inflammation
- Ocular allergy
Clinical work in this area reflects a focus on chronic immune-mediated eye disorders that can impair comfort, vision, and ocular surface integrity.
Inherited retinal dystrophies
The sponsor supports studies in retinitis pigmentosa, with attention to inherited disorders that progressively affect retinal function and visual performance.
- Retinitis pigmentosa
- Inherited retinal disease
- Visual impairment
This area includes genetically defined forms of retinal degeneration linked to US2H2A-related disease mechanisms.
Genetic eye disease and gene-targeted therapy
Trials also address Leber congenital amaurosis, with interest in rare monogenic retinal disorders associated with specific CEP290 variants.
- Leber congenital amaurosis
- CEP290-related disease
- Inherited blindness
These studies are centered on severe early-onset retinal conditions where preserving or improving photoreceptor and retinal signaling function is central.
Ocular therapeutics and topical treatment evaluation
Laboratoires Thea’s portfolio includes comparative research in ophthalmic anti-inflammatory treatment, with attention to effectiveness, safety, and tolerability in eye disease.
- Topical ophthalmic therapy
- Safety and tolerability
- Corneal and retinal outcomes
The research spans both surface eye disorders and degenerative retinal conditions, showing interest in distinct therapeutic needs across ophthalmology.
